Abstract
Cellular repressor of E1A-stimulated genes (CREG), a novel cellular protein, was discovered in 1998. Accumulating evidence, mainly from our laboratory, has suggested that CREG plays critical roles in reducing neointimal hyperplasia, maintaining vascular homeostasis, and promoting endothelial restoration. The study of CREG has the potential to offer new insights into both prevention and treatment of proliferative vascular disease, and will help us understand the processes of vascular repair after injury. It will also contribute to the development of new therapeutic strategies and devices, such as anti-in-stent restenosis stents. The present review summarizes our research on the molecular identity of CREG, and reviews the biological activities of CREG in regulating cell differentiation, proliferation, migration, and apoptosis of vascular smooth muscle cells and endothelial cells.
Keywords: Atherosclerosis, CREG, EC, restenosis, VSMC, heart disease, myocardial infarction, ischemic heart failure, inflammatory disease, vascular endothelial injury, platelet adherence, atherosclerotic plaque, myocardial revascularization, coronary stents, hyperplasia
Current Molecular Medicine
Title:CREG: A Possible Candidate for Both Prevention and Treatment of Proliferative Vascular Disease
Volume: 12 Issue: 10
Author(s): Y. Li, C.-H. Yan, S.-H. Li and Y.-L. Han
Affiliation:
Keywords: Atherosclerosis, CREG, EC, restenosis, VSMC, heart disease, myocardial infarction, ischemic heart failure, inflammatory disease, vascular endothelial injury, platelet adherence, atherosclerotic plaque, myocardial revascularization, coronary stents, hyperplasia
Abstract: Cellular repressor of E1A-stimulated genes (CREG), a novel cellular protein, was discovered in 1998. Accumulating evidence, mainly from our laboratory, has suggested that CREG plays critical roles in reducing neointimal hyperplasia, maintaining vascular homeostasis, and promoting endothelial restoration. The study of CREG has the potential to offer new insights into both prevention and treatment of proliferative vascular disease, and will help us understand the processes of vascular repair after injury. It will also contribute to the development of new therapeutic strategies and devices, such as anti-in-stent restenosis stents. The present review summarizes our research on the molecular identity of CREG, and reviews the biological activities of CREG in regulating cell differentiation, proliferation, migration, and apoptosis of vascular smooth muscle cells and endothelial cells.
Export Options
About this article
Cite this article as:
Li Y., Yan C.-H., Li S.-H. and Han Y.-L., CREG: A Possible Candidate for Both Prevention and Treatment of Proliferative Vascular Disease, Current Molecular Medicine 2012; 12 (10) . https://dx.doi.org/10.2174/156652412803833526
DOI https://dx.doi.org/10.2174/156652412803833526 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Current Status of CETP Inhibitors in the Treatment of Hyperlipidemia: An Update
Current Clinical Pharmacology Recent Clinical Trials of Pharmacologic Cardiovascular Interventions in Patients with Chronic Kidney Disease: An Update
Reviews on Recent Clinical Trials CXCR4-CXCL12-Dependent Inflammatory Network and Endothelial Progenitors
Current Medicinal Chemistry Periodontal Disease and Periodontal Tissue Regeneration
Current Stem Cell Research & Therapy Homocysteine and the Kidney
Current Drug Metabolism Differences in Functional Brain Activation and Hippocampal Volume Among Amnestic Mild Cognitive Impairment Subtypes
Current Alzheimer Research Coronary Pressure Measurement Based Decision Making for Percutaneous Coronary Intervention
Current Cardiology Reviews Homocysteine and Cerebral Ischemia: Pathogenic and Therapeutical Implications
Current Medicinal Chemistry Resveratrol and Cardiovascular Disease
Current Nutrition & Food Science Is the Vascular System a Main Target for Thyroid Hormones? From Molecular and Biochemical Findings to Clinical Perspectives
Current Vascular Pharmacology Methodologic Issues in the Validation of Putative Biomarkers and Surrogate Endpoints in Treatment Evaluation for Systemic Lupus Erythematosus
Endocrine, Metabolic & Immune Disorders - Drug Targets Usefulness of Home Blood Pressure in the Diagnosis and Control of Hypertension in Primary Care
Current Hypertension Reviews Apathy: A Conceptual Review
Current Psychiatry Research and Reviews Correlation between Serum 25 hydroxy vitamin D level and plasminogen activator inhibitor 1 in type 2 diabetic patients
Endocrine, Metabolic & Immune Disorders - Drug Targets Chronic Complications of Diabetes Mellitus: A Mini Review
Current Diabetes Reviews The Future of Collateral Artery Research
Current Cardiology Reviews Human Chorionic Gonadotropin: A Model Molecule For Oligopeptide-Based Drug Discovery
Endocrine, Metabolic & Immune Disorders - Drug Targets The Role of Vascular Cell Senescence in Atherosclerosis: Antisenescence as a Novel Therapeutic Strategy for Vascular Aging
Current Vascular Pharmacology Leptin and Vascular Smooth Muscle Cells
Current Pharmaceutical Design Improved Lipid Target Level Attainment in Patients with Peripheral Artery Disease
Current Vascular Pharmacology